Nanofiltration as a robust method contributing to viral safety of plasma‐derived therapeutics: 20 yearsʼ experience of the plasma protein manufacturers
Keyword(s):
Keyword(s):
1974 ◽
Vol 31
(03)
◽
pp. 395-402
◽
1964 ◽
Vol 11
(01)
◽
pp. 064-074
◽
Keyword(s):
1985 ◽
Vol 53
(01)
◽
pp. 005-007
◽
Keyword(s):
1983 ◽
Vol 43
(1)
◽
pp. 21-26
◽
Keyword(s):